Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 400

1.

Assessing interactions between mdm-2, p53, and bcl-2 as prognostic variables in muscle-invasive bladder cancer treated with neo-adjuvant chemotherapy followed by locoregional surgical treatment.

Maluf FC, Cordon-Cardo C, Verbel DA, Satagopan JM, Boyle MG, Herr H, Bajorin DF.

Ann Oncol. 2006 Nov;17(11):1677-86. Epub 2006 Sep 19.

2.

Prognostic factors in transitional cell cancer of the bladder: an emerging role for Bcl-2 and p53.

Ong F, Moonen LM, Gallee MP, ten Bosch C, Zerp SF, Hart AA, Bartelink H, Verheij M.

Radiother Oncol. 2001 Nov;61(2):169-75.

PMID:
11690683
3.

Clinical significance of p53, MDM2 and bcl-2 expression in transitional cell carcinoma of the bladder.

Uchida T, Minei S, Gao JP, Wang C, Satoh T, Baba S.

Oncol Rep. 2002 Mar-Apr;9(2):253-9.

PMID:
11836589
4.

Bcl-2 expression identifies patients with advanced bladder cancer treated by radiotherapy who benefit from neoadjuvant chemotherapy.

Cooke PW, James ND, Ganesan R, Burton A, Young LS, Wallace DM.

BJU Int. 2000 May;85(7):829-35.

5.
6.

Abnormal bcl-2 and pRb expression are independent correlates of radiation response in muscle-invasive bladder cancer.

Pollack A, Wu CS, Czerniak B, Zagars GK, Benedict WF, McDonnell TJ.

Clin Cancer Res. 1997 Oct;3(10):1823-9.

7.

Bcl-2 as a predictor of chemosensitivity and prognosis in primary epithelial ovarian cancer.

Mano Y, Kikuchi Y, Yamamoto K, Kita T, Hirata J, Tode T, Ishii K, Nagata I.

Eur J Cancer. 1999 Aug;35(8):1214-9.

PMID:
10615232
8.

Reciprocal expression of bcl-2 and p53 oncoproteins in urothelial dysplasia and carcinoma of the urinary bladder.

Li B, Kanamaru H, Noriki S, Yamaguchi T, Fukuda M, Okada K.

Urol Res. 1998;26(4):235-41.

PMID:
9759996
9.

The prevalence of bcl-2, p53, and Ki-67 immunoreactivity in transitional cell bladder carcinomas and their clinicopathologic correlates.

Nakopoulou L, Vourlakou C, Zervas A, Tzonou A, Gakiopoulou H, Dimopoulos MA.

Hum Pathol. 1998 Feb;29(2):146-54.

PMID:
9490274
10.

Bcl-2 and p53 expressions in invasive bladder cancers.

Kong G, Shin KY, Oh YH, Lee JJ, Park HY, Woo YN, Lee JD.

Acta Oncol. 1998;37(7-8):715-20.

PMID:
10050992
12.

Expression of bcl-2 and bcl-X in bladder cancer.

Kirsh EJ, Baunoch DA, Stadler WM.

J Urol. 1998 Apr;159(4):1348-53.

PMID:
9507882
13.
14.

Prognostic significance of p53, bcl-2, and Bax expression in early breast cancer.

Linjawi A, Kontogiannea M, Halwani F, Edwardes M, Meterissian S.

J Am Coll Surg. 2004 Jan;198(1):83-90.

PMID:
14698315
15.

Clinical significance of apoptosis-related factors p53, Mdm2, and Bcl-2 in advanced ovarian cancer.

Baekelandt M, Kristensen GB, Nesland JM, Tropé CG, Holm R.

J Clin Oncol. 1999 Jul;17(7):2061.

PMID:
10561259
16.

The biological, clinical and prognostic implications of p53 transcriptional pathways in breast cancers.

Abdel-Fatah TM, Powe DG, Agboola J, Adamowicz-Brice M, Blamey RW, Lopez-Garcia MA, Green AR, Reis-Filho JS, Ellis IO.

J Pathol. 2010 Mar;220(4):419-34. doi: 10.1002/path.2663.

PMID:
20044801
17.

p53 and p21 Expression levels predict organ preservation and survival in invasive bladder carcinoma treated with a combined-modality approach.

Garcia del Muro X, Condom E, Vigués F, Castellsagué X, Figueras A, Muñoz J, Solá J, Soler T, Capellà G, Germà JR.

Cancer. 2004 May 1;100(9):1859-67.

18.

Prognostic significance of bcl-2 expression in stage III breast cancer patients who had received doxorubicin and cyclophosphamide followed by paclitaxel as adjuvant chemotherapy.

Lee KH, Im SA, Oh DY, Lee SH, Chie EK, Han W, Kim DW, Kim TY, Park IA, Noh DY, Heo DS, Ha SW, Bang YJ.

BMC Cancer. 2007 Apr 12;7:63.

19.

Apoptosis in transitional cell carcinoma of bladder and its relation to proliferation and expression of p53 and bcl-2.

Amirghofran Z, Monabati A, Khezri A, Malek-Hosseini Z.

Pathol Oncol Res. 2004;10(3):154-8. Epub 2004 Sep 25.

20.

Apoptosis, p53, bcl-2, and Ki-67 in invasive bladder carcinoma: possible predictors for response to radiochemotherapy and successful bladder preservation.

Rödel C, Grabenbauer GG, Rödel F, Birkenhake S, Kühn R, Martus P, Zörcher T, Fürsich D, Papadopoulos T, Dunst J, Schrott KM, Sauer R.

Int J Radiat Oncol Biol Phys. 2000 Mar 15;46(5):1213-21.

PMID:
10725634
Items per page

Supplemental Content

Write to the Help Desk